StonvexLoading…
StonvexStonvexStonvexCore line items from ACGL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-27 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $4.55B | $4.52B | $19.93B | $14.99B | $9.89B |
Operating Income | Not available | Not available | $5.16B | Not available | Not available |
Net Income | Not available | $1.05B | $4.40B | $3.16B | $1.81B |
EPS (Diluted) | $2.44 | $2.88 | $11.60 | $8.26 | $4.70 |
Total Assets | Not available | $81.45B | $79.24B | $79.19B | $78.79B |
Total Liabilities | Not available | $57.26B | $55.03B | $55.47B | $55.75B |
Cash & Equivalents | Not available | $914.00M | $993.00M | $1.06B | $983.00M |
Free Cash Flow OCF − CapEx | Not available | $1.18B | $6.13B | $4.74B | $2.56B |
Shares Outstanding | Not available | 359.70M | 359.00M | 379.10M | 380.80M |